Amygdala Insula Retraining in the Management of Perimenopause Symptoms
Sponsored by Chronic Conditions Research Fund
About this trial
Last updated 3 months ago
Study ID
CCRF-AIR-PM
Status
Recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
38 to 60 Years
Female
Not accepting
Healthy Volunteers
Trial Timing
Started 3 months ago
What is this trial about?
The goal of this study is to evaluate a neuroplasticity-based mind-body intervention, Amygdala and Insula Retraining (AIR), compared to a wait-list control in individuals experiencing perimenopausal symptoms.
Our research questions include:
Does AIR reduce overall perimenopausal symptom burden compared to a wait-list control?
Does AIR improve sleep disturbance, vasomotor symptom interference, fatigue, mood, anxiety, and quality of life in perimenopausal individuals?
Are symptom changes associated with improvements in autonomic regulation and sleep parameters, as reflected by exploratory wearable measures including heart rate variability?
What are the participation requirements?
Inclusion Criteria
* Experiencing perimenopausal symptoms
* Meets STRAW+10 criteria based on self-assessment (-2 to +1c)
* Able to read and understand English
* Access to internet
Exclusion Criteria
* Pregnancy
* Presence of a severe psychiatric condition requiring immediate clinical intervention
* Uncontrolled thyroid disease or prolactinoma
* Active cancer treatment
* Inability to provide informed consent
* Any medical or psychiatric condition that, in the judgment of the investigator or study team, would interfere with safe participation or study completion